NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
Back to search
Official data from USPTO
HEAL TECHNOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
11/26/2024
Trademark type
Combined
Nice classes
5, 10
Filing date
04/04/2023
Registration date
11/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
11/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Pforzheim, DE
Examiner
ANDERSON, DANIELLE LYNN
Law office
M40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a teal web design attached to a swirl design consisting of a teal curved line above a gray curved line, to the left of the stylized word "HEAL" in teal above the stylized wording "TECHNOLOGY" in gray, the color white represents background and is not claimed as a feature of the mark.
Holders and representatives
Holders
Acandis GmbH
Representatives
Kathryn A. Gromlovits SHUMAKER, LOOP & KENDRICK, LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of strokes and neurovascular disorders; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of neurological disordersin particular neurological disorders affecting the central nervous systemthe peripheral nervous system and the autonomic nervous system; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of brain injuryin particular strokebrain trauma and global ischemia; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of neurodegenerative disorders; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of stroke and dementia in particularAlzheimer's diseaseParkinson's diseasesenile dementia and Huntington's disease; Pharmaceutical preparations and additives in the nature of dietary supplements for neuroprotection in particular for treatment and alleviation of symptoms of strokes; Medical instruments and apparatusdelivery apparatus for fibrin sealant and fibrin scaffold; Bio-functional antithrombogenic and endothelialisation coatingsdrug delivery agents in the form of a coating for stents that facilitate the delivery of a wide range of pharmaceuticals for treatment of neurovascular diseases; Biological skin tissue intended for subsequent implantation; Tissues for surgical use being surgical implants comprised of living tissues; Pharmaceutical preparations in liquid form for the treatment of neurological and neurovascular disorders; pharmaceutical preparationsliquid embolic agents
Class 10
Surgical and medical apparatus for use in treating stroke and blockage or inflammation of cerebral vessels; surgical devices and instruments; Medical stents in the nature of surgical implant made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Grafts being surgical implants made of artificial materials; Flow diverterssurgical implants comprised of artificial materials; Medical guidewires and medical filters being blood filtersfor use in the fields of RadiologyCardiology and Neurology for the treatment of strokes and neurovascular disorders; Surgical and medical instrumentsstent-retrievers and stents for blood and blood components for medical purposes for use in the radiologycardiology and neurology sectorsin particular for treating strokes and neurovascular disorders; Medical recanalisation devices for use in treating blood clots; Medical embolisation devices for use in treating hemoptysis; Medical application systems for surgical and medical apparatusdevices and instrumentsin particular catheters; Medical devicespulse generators used with a neurostimulation system for neurostimulation; Prosthetic tissues for vascular use; Medical electrodes for the simulation of nerve paths; Medical electrodes for the treatment of epilepsy and Alzheimer's disease
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2024
PUBO
PUBLISHED FOR OPPOSITION
09/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/14/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/14/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/14/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/30/2024
GNRT
NON-FINAL ACTION E-MAILED
07/30/2024
CNRT
NON-FINAL ACTION WRITTEN
07/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/27/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/27/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/27/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/08/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/08/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/08/2024
GNRT
NON-FINAL ACTION E-MAILED
01/08/2024
CNRT
NON-FINAL ACTION WRITTEN
01/08/2024
DOCK
ASSIGNED TO EXAMINER
12/30/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/27/2023
NWAP
NEW APPLICATION ENTERED
04/07/2023
Continuous trademark protection
Get notified about every new filing that threatens HEAL TECHNOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.